Kestra Medical Technologies, Ltd.
KMTS
$15.38
-$1.12-6.79%
NASDAQ
04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | ||
---|---|---|---|---|---|
Net Income | -20.92% | -- | -- | -- | |
Total Depreciation and Amortization | -31.07% | -- | -- | -- | |
Total Amortization of Deferred Charges | 129.51% | -- | -- | -- | |
Total Other Non-Cash Items | 467.03% | -- | -- | -- | |
Change in Net Operating Assets | -259.54% | -- | -- | -- | |
Cash from Operations | -7.44% | -- | -- | -- | |
Capital Expenditure | -88.52% | -- | -- | -- | |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | |
Divestitures | -- | -- | -- | -- | |
Other Investing Activities | -0.70% | -- | -- | -- | |
Cash from Investing | -90.60% | -- | -- | -- | |
Total Debt Issued | -- | -- | -- | -- | |
Total Debt Repaid | -- | -- | -- | -- | |
Issuance of Common Stock | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | |
Issuance of Preferred Stock | 37.87% | -- | -- | -- | |
Repurchase of Preferred Stock | -- | -- | -- | -- | |
Total Dividends Paid | -- | -- | -- | -- | |
Other Financing Activities | 375.98% | -- | -- | -- | |
Cash from Financing | 324.91% | -- | -- | -- | |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
Net Change in Cash | 3,503.26% | -- | -- | -- | |